martes, 16 de septiembre de 2025

Critics call on Sarepta to show how it’s measuring gene therapy’s performance Muscular dystrophy patients are using Elevidys without key data, experts warn

https://www.statnews.com/2025/09/16/sarepta-elevidys-duchenne-treatment-measurement-concerns/

No hay comentarios: